HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of p38 mitogen-activated protein kinase unmasks a CD30-triggered apoptotic pathway in anaplastic large cell lymphoma cells.

Abstract
CD30, a non-death domain-containing member of the tumor necrosis factor receptor superfamily, triggers apoptosis in anaplastic large cell lymphoma cells. The CD30 signaling pathways that lead to the induction of apoptosis are poorly defined. Here, we show that the induction of apoptosis by CD30 requires concurrent inhibition of p38 mitogen-activated protein kinase, which itself is activated by engagement of CD30 with CD30 ligand. Treatment of anaplastic large cell lymphoma cells with CD30 ligand and pharmacologic inhibitors of p38 mitogen-activated protein kinase, but not with CD30 ligand or inhibitors alone, triggered the activation of caspase-8 and the induction of apoptosis. Caspase-8 activation occurred within a few hours (2.5-4 h) after receptor triggering, was unaffected by the neutralization of ligands for the death domain-containing receptors TNFR1, Fas, DR3, DR4, or DR5, but was abolished by the expression of a dominant-negative form of the adaptor protein FADD. Importantly, we show that expression of the caspase-8 inhibitor c-FLIP(S) is strongly induced by the CD30 ligand, and that this is dependent on the activation of p38 mitogen-activated protein kinase. Thus, we provide evidence that the induction of apoptosis by CD30 in anaplastic large cell lymphoma cells is normally circumvented by the activation of p38 mitogen-activated protein kinase. These findings have implications for CD30-targeted immunotherapy of anaplastic large cell lymphoma.
AuthorsSergey V Krysov, Tania F Rowley, Aymen Al-Shamkhani
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 6 Issue 2 Pg. 703-11 (Feb 2007) ISSN: 1535-7163 [Print] United States
PMID17308066 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • CFLAR protein, human
  • Caspase Inhibitors
  • Fas Ligand Protein
  • Fas-Associated Death Domain Protein
  • Ki-1 Antigen
  • Receptors, TNF-Related Apoptosis-Inducing Ligand
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Member 25
  • Receptors, Tumor Necrosis Factor, Type I
  • TNFRSF10A protein, human
  • TNFRSF25 protein, human
  • Tumor Necrosis Factor-alpha
  • fas Receptor
  • p38 Mitogen-Activated Protein Kinases
  • Caspase 3
  • Caspase 8
Topics
  • Apoptosis (drug effects)
  • Blotting, Western
  • CASP8 and FADD-Like Apoptosis Regulating Protein (metabolism)
  • Caspase 3 (metabolism)
  • Caspase 8 (metabolism)
  • Caspase Inhibitors
  • Cell Cycle (drug effects)
  • Fas Ligand Protein (metabolism)
  • Fas-Associated Death Domain Protein (metabolism)
  • Humans
  • Ki-1 Antigen (immunology, pharmacology)
  • Lymphoma, Large-Cell, Anaplastic (genetics, metabolism, pathology)
  • Receptors, TNF-Related Apoptosis-Inducing Ligand (metabolism)
  • Receptors, Tumor Necrosis Factor (metabolism)
  • Receptors, Tumor Necrosis Factor, Member 25 (metabolism)
  • Receptors, Tumor Necrosis Factor, Type I (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Transfection
  • Tumor Cells, Cultured (drug effects)
  • Tumor Necrosis Factor-alpha (metabolism)
  • fas Receptor (metabolism)
  • p38 Mitogen-Activated Protein Kinases (antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: